SearchDictionaryMobileLogin Register FREE

Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey.

AuthorsLaurent Sailler, Camille Attane, Fleur Michenot, Jean-Marie Canonge, Lionel Rostaing, Elizabeth Arlet-Suau, Philippe Arlet, François Launay, Jean-Louis Montastruc, Maryse Lapeyre-Mestre
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 66 Issue 2 Pg. 320-2 (Aug 2008) ISSN: 1365-2125 England
PMID18485050 (Publication Type: Letter)
Chemical References
  • Antibodies, Monoclonal
  • Immunologic Factors
  • rituximab
Topics
  • Acquired Immunodeficiency Syndrome (drug therapy)
  • Adult
  • Aged
  • Antibodies, Monoclonal (adverse effects)
  • Drug Labeling
  • Female
  • Humans
  • Immunocompromised Host (drug effects)
  • Immunologic Factors (adverse effects)
  • Male
  • Middle Aged
  • Treatment Outcome